A recent study by Yang et al. [41] revealed that CAR‐NK cells targeting CD19/CD20 exhibited enhanced cytotoxicity against acute lymphoblastic leukemia (ALL), even in the absence of target antigens. Here, CD19 is linked to acute lymphoblastic leukemia.